CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

online mindfulness groupWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug489 COVID19 vaccine Wiki 1.00
drug2176 Saline Wiki 0.38

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Feasibility and Acceptability of Online Based Mindfulness Interventions to Relieve Distress During COVID-19 Outbreak in a Chinese Population: a Proof-of-concept Trial

The investigators had designed weekly mindfulness sessions (details see intervention below), which is free-of-charge and will be made available to general public who feel distressed during the outbreak of COVID-19. Face-to-face delivery of mindfulness interventions was not possible due to mandatory quarantine. The investigators hypothesize that this intervention is feasible and acceptable by the participants. As secondary outcomes, the investigators also hypothesize that the intervention can reduce stress, depressive and anxiety symptoms and enhance participants' sense of coherence This will be a quasi-experimental study. Participants will be invited to fill in an online informed consent and questionnaire around 2 days before each mindfulness online session and another set of questionnaire immediately after each session (see outcome measures). Participants will be identified by their e-mail and therefore serial data could be obtained.

NCT04346082 Stress Behavioral: online mindfulness group

Primary Outcomes

Description: the rate of recruitment to recruit participants

Measure: rate of recruitment

Time: from recruitment to end of study, up to 1 year

Description: the number of attendance to the mindfulness online group

Measure: rate of attendence

Time: from recruitment to end of study, up to 1 year

Secondary Outcomes

Description: Depression, anxiety and stress will be measured using the Depression, Anxiety and Stress Scale (DASS-21), which was validated in Chinese population with high internal consistency. The 21-item DASS-21 has three subscales designed to measure depression, anxiety and stress, with each subscale containing 7 items. Participants are required to rate each statement in DASS-21 using a 4-point Likert scale from "did not apply to me at all" to "applied to me very much or most of the time" in the prior one week. Higher scores represent higher level of psychological distress.

Measure: Depression, Anxiety and Stress Scale (DASS-21)

Time: on recruitment, after each online mindfulness sessions (weekly) until end of study, up to 1 year

Description: Sense of Coherence (SOC) will be assessed by the 13-item Sense of Coherence Scale (SOC-13) based on Antonovsky (1987)'s measurement of the comprehensibility, manageability, and meaningfulness of a person's life events . Participants will rate each statement in SOC-13 on a 7-point Likert scale from "very often" to "very seldom or never". SOC-13 has been validated in Chinese population with high internal consistency. The higher the score, the higher the sense of coherence

Measure: Sense of Coherence Scale

Time: on recruitment, after each online mindfulness sessions (weekly) until end of study, up to 1 year

No related HPO nodes (Using clinical trials)